US Bancorp’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

US Bancorp’s Portfolio OCAT Stock Details OCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,000	Closed	-$8K	–	3788
2015 Q4	$8K	Hold	1,000	–	–	﹤0.01%	3128
2015 Q3	$4K	Hold	1,000	–	–	﹤0.01%	3329
2015 Q2	$5K	Sell	1,000 -500	-33%	-$3.2K	﹤0.01%	3315
2015 Q1	$9K	Buy	+1,500	New	+$9.61K	﹤0.01%	3166

US Bancorp's OCAT Position: Q1 2016 in Review

US Bancorp sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 1,000 shares — an estimated $8K sold.

US Bancorp first reported a position in OCAT in Q1 2015 and held it in 4 quarters. The position peaked at $9K in Q1 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

US Bancorp reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
US Bancorp sold 1,000 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $8K.
US Bancorp first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q1 2015 and held it in 4 quarters.
US Bancorp's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $9K in Q1 2015.
1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on US Bancorp's 13F filing for Q1 2016, filed 13 May 2016.